|
Volumn 32, Issue 5, 2012, Pages 1391-1396
|
Presentation and prognosis of shrinking lung syndrome in systemic lupus erythematosus: Report of four cases
|
Author keywords
Lupus erythematosus; Respiratory mechanics; Respiratory paralysis physiopathology; Respiratory tract diseases; Systemic
|
Indexed keywords
AZATHIOPRINE;
CARDIOLIPIN ANTIBODY;
CHLOROQUINE;
CYCLOPHOSPHAMIDE;
HEPARIN;
METHYLPREDNISOLONE;
PREDNISONE;
WARFARIN;
ADOLESCENT;
ADULT;
ARTICLE;
ATELECTASIS;
BRAZIL;
CASE REPORT;
CLINICAL FEATURE;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG MEGADOSE;
DYSPNEA;
FEMALE;
FORCED EXPIRATORY VOLUME;
HEMODIALYSIS;
HUMAN;
KIDNEY FAILURE;
LUNG DISEASE;
LUNG FIBROSIS;
LUNG FUNCTION;
LUNG VOLUME;
LUPUS ERYTHEMATOSUS NEPHRITIS;
LYMPHOCYTE COUNT;
MAINTENANCE THERAPY;
PATIENT CARE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROGNOSIS;
SHRINKING LUNG SYNDROME;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THORAX PAIN;
THORAX RADIOGRAPHY;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADOLESCENT;
CHEST PAIN;
DRUG THERAPY, COMBINATION;
DYSPNEA;
FATAL OUTCOME;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LUNG;
LUNG DISEASES;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
RESPIRATORY FUNCTION TESTS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 84863626083
PISSN: 01728172
EISSN: 1437160X
Source Type: Journal
DOI: 10.1007/s00296-011-1863-5 Document Type: Article |
Times cited : (16)
|
References (12)
|